FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035447103> ?p ?o ?g. }

• W3035447103 endingPage "2234" @default.
• W3035447103 startingPage "2226" @default.
• W3035447103 abstract "Cherubism is a rare autosomal dominant disease whose severity ranges widely, from asymptomatic to life-threatening. Bilateral symmetrical painless expansion of the mandible and maxilla resulting in a typical appearance of the face resembling a cherub, are the highlighted features of the condition. In most cases, cherubism-induced lesions in the jaws appear around the age of 3 years and tend to expand and increase in numbers until puberty. Treatment options for cherubism range from observation to surgical correction and various pharmacologic therapies. Given the excess sensitivity of cherubism osteoclasts to RANKL (receptor activator of nuclear factor κB ligand) and the positive effects of denosumab (XGEVA; Amgen, Thousand Oaks, CA) treatment in patients with giant cell granuloma, we have designed a treatment based on denosumab for 2 cherubism patients that achieves what we consider promising results. Cherubism is a rare autosomal dominant disease whose severity ranges widely, from asymptomatic to life-threatening. Bilateral symmetrical painless expansion of the mandible and maxilla resulting in a typical appearance of the face resembling a cherub, are the highlighted features of the condition. In most cases, cherubism-induced lesions in the jaws appear around the age of 3 years and tend to expand and increase in numbers until puberty. Treatment options for cherubism range from observation to surgical correction and various pharmacologic therapies. Given the excess sensitivity of cherubism osteoclasts to RANKL (receptor activator of nuclear factor κB ligand) and the positive effects of denosumab (XGEVA; Amgen, Thousand Oaks, CA) treatment in patients with giant cell granuloma, we have designed a treatment based on denosumab for 2 cherubism patients that achieves what we consider promising results." @default.
• W3035447103 created "2020-06-19" @default.
• W3035447103 creator A5019674214 @default.
• W3035447103 creator A5032325630 @default.
• W3035447103 creator A5056389887 @default.
• W3035447103 creator A5067996346 @default.
• W3035447103 creator A5074635576 @default.
• W3035447103 creator A5076189370 @default.
• W3035447103 creator A5082551613 @default.
• W3035447103 date "2020-12-01" @default.
• W3035447103 modified "2023-10-01" @default.
• W3035447103 title "Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism" @default.
• W3035447103 cites W1521598031 @default.
• W3035447103 cites W1579111286 @default.
• W3035447103 cites W1785649545 @default.
• W3035447103 cites W1857704453 @default.
• W3035447103 cites W1889100959 @default.
• W3035447103 cites W1993218448 @default.
• W3035447103 cites W2002522727 @default.
• W3035447103 cites W2010777991 @default.
• W3035447103 cites W2016260864 @default.
• W3035447103 cites W2025239337 @default.
• W3035447103 cites W2099963180 @default.
• W3035447103 cites W2127403047 @default.
• W3035447103 cites W2148607491 @default.
• W3035447103 cites W2159152276 @default.
• W3035447103 cites W2167798404 @default.
• W3035447103 cites W2324825062 @default.
• W3035447103 cites W2480218419 @default.
• W3035447103 cites W2918050696 @default.
• W3035447103 cites W2950738816 @default.
• W3035447103 cites W2969312520 @default.
• W3035447103 cites W3012527913 @default.
• W3035447103 doi "https://doi.org/10.1016/j.joms.2020.06.016" @default.
• W3035447103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32649899" @default.
• W3035447103 hasPublicationYear "2020" @default.
• W3035447103 type Work @default.
• W3035447103 sameAs 3035447103 @default.
• W3035447103 citedByCount "6" @default.
• W3035447103 countsByYear W30354471032021 @default.
• W3035447103 countsByYear W30354471032022 @default.
• W3035447103 countsByYear W30354471032023 @default.
• W3035447103 crossrefType "journal-article" @default.
• W3035447103 hasAuthorship W3035447103A5019674214 @default.
• W3035447103 hasAuthorship W3035447103A5032325630 @default.
• W3035447103 hasAuthorship W3035447103A5056389887 @default.
• W3035447103 hasAuthorship W3035447103A5067996346 @default.
• W3035447103 hasAuthorship W3035447103A5074635576 @default.
• W3035447103 hasAuthorship W3035447103A5076189370 @default.
• W3035447103 hasAuthorship W3035447103A5082551613 @default.
• W3035447103 hasConcept C122246415 @default.
• W3035447103 hasConcept C126322002 @default.
• W3035447103 hasConcept C141071460 @default.
• W3035447103 hasConcept C142724271 @default.
• W3035447103 hasConcept C16005928 @default.
• W3035447103 hasConcept C170493617 @default.
• W3035447103 hasConcept C199343813 @default.
• W3035447103 hasConcept C2776286101 @default.
• W3035447103 hasConcept C2776541429 @default.
• W3035447103 hasConcept C2777134543 @default.
• W3035447103 hasConcept C2777910003 @default.
• W3035447103 hasConcept C2779428903 @default.
• W3035447103 hasConcept C2780134995 @default.
• W3035447103 hasConcept C71924100 @default.
• W3035447103 hasConcept C77076574 @default.
• W3035447103 hasConcept C88045685 @default.
• W3035447103 hasConceptScore W3035447103C122246415 @default.
• W3035447103 hasConceptScore W3035447103C126322002 @default.
• W3035447103 hasConceptScore W3035447103C141071460 @default.
• W3035447103 hasConceptScore W3035447103C142724271 @default.
• W3035447103 hasConceptScore W3035447103C16005928 @default.
• W3035447103 hasConceptScore W3035447103C170493617 @default.
• W3035447103 hasConceptScore W3035447103C199343813 @default.
• W3035447103 hasConceptScore W3035447103C2776286101 @default.
• W3035447103 hasConceptScore W3035447103C2776541429 @default.
• W3035447103 hasConceptScore W3035447103C2777134543 @default.
• W3035447103 hasConceptScore W3035447103C2777910003 @default.
• W3035447103 hasConceptScore W3035447103C2779428903 @default.
• W3035447103 hasConceptScore W3035447103C2780134995 @default.
• W3035447103 hasConceptScore W3035447103C71924100 @default.
• W3035447103 hasConceptScore W3035447103C77076574 @default.
• W3035447103 hasConceptScore W3035447103C88045685 @default.
• W3035447103 hasIssue "12" @default.
• W3035447103 hasLocation W30354471031 @default.
• W3035447103 hasOpenAccess W3035447103 @default.
• W3035447103 hasPrimaryLocation W30354471031 @default.
• W3035447103 hasRelatedWork W1599706305 @default.
• W3035447103 hasRelatedWork W1999991291 @default.
• W3035447103 hasRelatedWork W2330200613 @default.
• W3035447103 hasRelatedWork W2354421783 @default.
• W3035447103 hasRelatedWork W2623111477 @default.
• W3035447103 hasRelatedWork W2999684752 @default.
• W3035447103 hasRelatedWork W3035447103 @default.
• W3035447103 hasRelatedWork W3209218345 @default.
• W3035447103 hasRelatedWork W4243361694 @default.
• W3035447103 hasRelatedWork W2319714600 @default.
• W3035447103 hasVolume "78" @default.
• W3035447103 isParatext "false" @default.

• next